Smith+Nephew: Cementless knee implant
Smith+Nephew (NYSE:SNN) has a bevy of devices to debut this year from its orthopedics, sports medicine & ENT and advanced wound management lines.
Topping the list is its first cementless knee implant, set to debut in the second half of the year, CEO Roland Diggelmann told investors in February.
“This is probably the one portfolio gap that we’ve needed to address. The aim is to access this high-growth segment, and is an important part of our plans to accelerate in Knees,” Diggelmann said.
